BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 16739203)

  • 1. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.
    Ruperto N; Ravelli A; Oliveira S; Alessio M; Mihaylova D; Pasic S; Cortis E; Apaz M; Burgos-Vargas R; Kanakoudi-Tsakalidou F; Norambuena X; Corona F; Gerloni V; Hagelberg S; Aggarwal A; Dolezalova P; Saad CM; Bae SC; Vesely R; Avcin T; Foster H; Duarte C; Herlin T; Horneff G; Lepore L; van Rossum M; Trail L; Pistorio A; Andersson-Gäre B; Giannini EH; Martini A;
    Arthritis Rheum; 2006 Jun; 55(3):355-63. PubMed ID: 16739203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set.
    Ruperto N; Ravelli A; Cuttica R; Espada G; Ozen S; Porras O; Sztajnbok F; Falcini F; Kasapcopur O; Venning H; Bica B; Merino R; Coto C; Ros J; Susic G; Gamir ML; Minden K; See Y; Uziel Y; Mukamel M; Riley P; Zulian F; Olivieri AN; Cimaz R; Girschick H; Rumba I; Cavuto S; Pistorio A; Lovell DJ; Martini A; ;
    Arthritis Rheum; 2005 Sep; 52(9):2854-64. PubMed ID: 16142708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Paediatric Rheumatology International Trials Organization (PRINTO).
    Ruperto N; Bazso A; Ravelli A; Malattia C; Filocamo G; Pistorio A; Rodriguez Lozano AL; Viola S; Martini A;
    Lupus; 2007; 16(8):670-6. PubMed ID: 17711906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Childhood Health Assessment Questionnaire in active juvenile systemic lupus erythematosus.
    Meiorin S; Pistorio A; Ravelli A; Iusan SM; Filocamo G; Trail L; Oliveira S; Cuttica R; Espada G; Alessio M; Mihaylova D; Cortis E; Martini A; Ruperto N;
    Arthritis Rheum; 2008 Aug; 59(8):1112-9. PubMed ID: 18668598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International consensus on preliminary definitions of improvement in adult and juvenile myositis.
    Rider LG; Giannini EH; Brunner HI; Ruperto N; James-Newton L; Reed AM; Lachenbruch PA; Miller FW;
    Arthritis Rheum; 2004 Jul; 50(7):2281-90. PubMed ID: 15248228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study.
    Ruperto N; Ravelli A; Pistorio A; Ferriani V; Calvo I; Ganser G; Brunner J; Dannecker G; Silva CA; Stanevicha V; Cate RT; van Suijlekom-Smit LW; Voygioyka O; Fischbach M; Foeldvari I; Hilario O; Modesto C; Saurenmann RK; Sauvain MJ; Scheibel I; Sommelet D; Tambic-Bukovac L; Barcellona R; Brik R; Ehl S; Jovanovic M; Rovensky J; Bagnasco F; Lovell DJ; Martini A; ;
    Arthritis Rheum; 2008 Jan; 59(1):4-13. PubMed ID: 18163404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis.
    Ruperto N; Pistorio A; Ravelli A; Rider LG; Pilkington C; Oliveira S; Wulffraat N; Espada G; Garay S; Cuttica R; Hofer M; Quartier P; Melo-Gomes J; Reed AM; Wierzbowska M; Feldman BM; Harjacek M; Huppertz HI; Nielsen S; Flato B; Lahdenne P; Michels H; Murray KJ; Punaro L; Rennebohm R; Russo R; Balogh Z; Rooney M; Pachman LM; Wallace C; Hashkes P; Lovell DJ; Giannini EH; Gare BA; Martini A; ;
    Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1533-41. PubMed ID: 20583105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
    Ringold S; Chon Y; Singer NG
    Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
    Ruperto N; Martini A
    Georgian Med News; 2008 Mar; (156):68-74. PubMed ID: 18403813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
    American College of Rheumatology Committee to Reevaluate Improvement Criteria
    Arthritis Rheum; 2007 Mar; 57(2):193-202. PubMed ID: 17330293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and strategies for reevaluating the ACR20.
    Felson DT; Furst DE; Boers M
    J Rheumatol; 2007 May; 34(5):1184-7. PubMed ID: 17477484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to letter by Isenberg and Gordon commenting on the Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus.
    Ruperto N; Ravelli A; Martini A;
    Arthritis Rheum; 2006 Nov; 54(11):3723-4. PubMed ID: 17075891
    [No Abstract]   [Full Text] [Related]  

  • 15. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.
    Zulian F; Woo P; Athreya BH; Laxer RM; Medsger TA; Lehman TJ; Cerinic MM; Martini G; Ravelli A; Russo R; Cuttica R; de Oliveira SK; Denton CP; Cozzi F; Foeldvari I; Ruperto N
    Arthritis Rheum; 2007 Mar; 57(2):203-12. PubMed ID: 17330294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.
    Ruperto N; Ravelli A; Murray KJ; Lovell DJ; Andersson-Gare B; Feldman BM; Garay S; Kuis W; Machado C; Pachman L; Prieur AM; Rider LG; Silverman E; Tsitsami E; Woo P; Giannini EH; Martini A; ;
    Rheumatology (Oxford); 2003 Dec; 42(12):1452-9. PubMed ID: 12832713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus.
    Gutiérrez-Suárez R; Ruperto N; Gastaldi R; Pistorio A; Felici E; Burgos-Vargas R; Martini A; Ravelli A
    Arthritis Rheum; 2006 Sep; 54(9):2989-96. PubMed ID: 16947634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials.
    ; Mikdashi JA; Esdaile JM; Alarcón GS; Crofford L; Fessler BJ; Shanberg L; Brunner H; Gall V; Kalden JR; Lockshin MD; Liang MH; Roberts N; Schneider M
    Lupus; 2007; 16(6):418-25. PubMed ID: 17664232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome measurements in scleroderma: results from a delphi exercise.
    Gazi H; Pope JE; Clements P; Medsger TA; Martin RW; Merkel PA; Kahaleh B; Wollheim FA; Baron M; Csuka ME; Emery P; Belch JF; Hayat S; Lally EV; Korn JH; Czirjak L; Herrick A; Voskuyl AE; Bruehlmann P; Inanc M; Furst DE; Black C; Ellman MH; Moreland LW; Rothfield NF; Hsu V; Mayes M; McKown KM; Krieg T; Siebold JR
    J Rheumatol; 2007 Mar; 34(3):501-9. PubMed ID: 17299843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
    J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.